High-Throughput Production of Influenza Virus-Like Particle (VLP) Array by Using VLP-factory™, a MultiBac Baculoviral Genome Customized for Enveloped VLP Expression-Reference-Cited by-同舟云学术

High-Throughput Production of Influenza Virus-Like Particle (VLP) Array by Using VLP-factory™, a MultiBac Baculoviral Genome Customized for Enveloped VLP Expression

Published:2019 Issue: Volume: Page:213-226
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Sari-Ak Duygu,Bahrami Shervin,Laska Magdalena J.,Drncova Petra,Fitzgerald Daniel J.,Schaffitzel Christiane,Garzoni Frederic,Berger Imre

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-9624-7_10

Reference38 articles.

1. Cox MM, Hollister JR (2000) FluBlok: a next generation influenza vaccine manufactured in insect cells. Biologicals 37(3):182–189

2. Schiller JT, Lowy DR (2006) Prospects for cervical cancer prevention by human papillomavirus vaccination. Cancer Res 66(21):10229–10232

3. Temchura V, Überla K (2017) Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines. Curr Opin HIV AIDS 12(3):272–277

4. Charlton Hume HK, Lua LH (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35(35 Pt A):4480–4485

5. Jeong H, Seong BL (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol 55(3):220–230

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus-like Particles as Vaccines for Allergen-Specific Therapy: An Overview of Current Developments;International Journal of Molecular Sciences;2024-07-06

2. Role of Natural Binding Proteins in Therapy and Diagnostics;Life;2024-05-15

3. Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens;Frontiers in Immunology;2022-02-21

4. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases;Frontiers in Microbiology;2022-01-03

5. VLP‐factory™ and ADDomer © : Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display;Current Protocols;2021-03